Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03086135
Other study ID # CBAS5539
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 9, 2017
Est. completion date June 20, 2019

Study information

Verified date January 2020
Source Cochlear
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To study the initial experience with implanting and fitting the new Bone conduction system in patients with conductive, mixed or Single sided Sensorineural deafness.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date June 20, 2019
Est. primary completion date October 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult subjects (18 years or older) - Subject with conductive or mixed hearing loss in the ear to be implanted. Bone conduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2 and 4 kHz) of 55 dB HL. OR Subject with single-sided sensorineural deafness who is a candidate for Baha surgery. Air conduction thresholds with a pure tone average PTA4 of 20 dB HL (mean of 0.5, 1, 2 and 3 kHz) in the good ear OR subject who is indicated for an AC CROS but-for some reason-cannot or will not use an AC CROS (Air Conduction-Contralateral Routing of Signal). - Signed informed consent - Previous experience from amplified sound though a non-surgical solution. (For example but not limited to Hearing aid, CROS device, Bone conductional hearing device on headband/ softband) Exclusion Criteria: - Uncontrolled diabetes as judged by the investigator. - Condition that could jeopardise osseointegration and/or wound healing (e.g. osteoporosis, psoriasis, long-term systemic use of corticosteroids) or condition that may have an impact on the outcome of the investigation as judged by the investigator. - Insufficient bone quality and quantity for implantation of a BI300 Implant. - Subject that has received radiotherapy in the area of implantation, or is planned for such radiotherapy during the study period - Use of ototoxic drugs that could be harmful to the hearing, as judged by the investigator - Unable to follow investigational procedures, e.g. to complete quality of life scales. - Participation in another clinical investigation with pharmaceutical and/or device.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Osia System
An external Sound Processor captures and digitize the sound which is transferred to the internal implant where it is converted to an electrical signal. The electrical signal is further transferred as a vibration through an osseointegrated implant to the mastoid bone and eventually to the cochlea.

Locations

Country Name City State
Australia The Royal Victorian Eye and Ear Hospital East Melbourne Victoria
Germany University Medical Center Freiburg Freiburg Baden-Württemberg
Netherlands Radboud University Medical Center Nijmegen
Poland World Hearing Center Institute of Physiology and Pathology of Hearing Kajetany Nadarzyn
United States University of Michigan Ann Arbor Michigan

Sponsors (1)

Lead Sponsor Collaborator
Cochlear

Countries where clinical trial is conducted

United States,  Australia,  Germany,  Netherlands,  Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hearing Performance: Threshold Audiometry, Pure Tone Average of 4 Frequencies, PTA4, Unaided Versus OSIA System at 3 Months The change of hearing performance from the unaided hearing situation before surgery to the aided hearing situation with the OSIA system at 3 month, measured as free-field hearing test; Threshold audiometry PTA4 (mean of 500, 1000, 2000 and 4000 Hz) is presented. A Pure Tone Average (PTA) refers to the average of hearing threshold levels at a set of specified frequencies: typically 500, 1000, 2000 and 4000 Hz. This value gives a snapshot of an individual's hearing level. If PTA is <25 dB, the overall hearing would be considered to be within normal limits. With a PTA of 95 dB, the hearing would be considered in the profound range. The units reported for PTA4 are decibels (dB). The results presented here are the difference of PTA4 unaided and PTA4 aided with the Osia system. An uaided PTA4 values should be higher than a aided PTA4 if the hearing device is effective. A lower or more negative score is more desirable and reflects a better ability to hear softer sounds. Baseline before surgery, 3 months after surgery
Primary Adaptive Speech Recognition in Noise, Unaided Versus OSIA System at 3 Months. The change of hearing performance from the unaided hearing situation before surgery to the aided hearing situation with the OSIA System at 3 months measured as free field hearing test Adaptive speech recognition in noise, is presented. Adaptive speech recognition in noise was measured as Signal to Noise Ratio (SNR). The noise was kept constant at 65 dB SPL and the speech was adapted in dB steps to establish the Speech-to-Noise Ratio (SNR) providing a 50% level of understanding. A ratio of 0 reflects the ability to correctly hear sentences at 65 dB, in the presence of 65 dB background noise. A negative SNR-value reflects the ability to correctly hear sentences below 65 dB, for example if 50% of the speech is received correctly at 55 dB the SNR value is -10. A positive SNR-value (Speech to Noise Ratio) reflects the ability to correctly hear sentences presented above 65 dB. A lower or more negative score is more desirable and reflects abetter hearing in a noisy enviroment. Baseline before surgery, 3 months after surgery
Secondary Hearing Performance: Threshold Audiometry, Pure Tone Average, PTA4, Unaided Versus OSIA System at 4 Weeks, 6 and 12 Months The change of hearing performance from the unaided hearinhg situation before surgery to the aided hearing situation with the OSIA system at 4 weeks, 6 and 12 months, measured as free-field hearing test: Threshold audiometry PTA4 (mean of 500, 1000, 2000 and 4000 Hz) is presented. A Pure Tone Average (PTA) refers to the average of hearing threshold levels at a set of specified frequencies: typically 500, 1000, 2000 and 4000 Hz. This value gives a snapshot of an individual's hearing level. If PTA is <25 dB, the overall hearing would be considered to be within normal limits. With a PTA of 95 dB, the hearing would be considered in the profound range. The units reported for PTA4 are decibels (dB). The results presented here are the difference of PTA4 unaided and PTA4 aided with the Osia system. An uaided PTA4 values should be higher than a aided PTA4 if the hearing device is effective. A lower or more negative score is more desirable and reflects a better ability to hear softer sounds. Baseline before surgery, 4 weeks, 6 and 12 months after surgery
Secondary Hearing Performance: Threshold Audiometry Individual Frequences, Unaided Versus OSIA System at 4 Weeks, 3, 6 and 12 Months The change of hearing performance from the unaided hearing situation before surgery to the aided hearing situation with the OSIA system at 4 weeks, 3, 6 and 12 months, measured as free-field hearing test: Threshold audiometry (0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 kHz) is presented. This value gives a snapshot of an individual's hearing level. If PTA is <25 dB, the overall hearing would be considered to be within normal limits. With a PTA of 95 dB, the hearing would be considered in the profound range. The units reported for PTA4 are decibels (dB). The results presented here are the difference of the unaided hearing level expressed in dB and the hearing level aided with the Osia system at different time points. An unaided value should be higher than a aided if the hearing device is effective. A lower or more negative score is therefor more desirable and reflects a better ability to hear at the specified frequency. Baseline before surgery, 4 weeks, 3, 6 and 12 months after surgery.
Secondary Speech in Quiet at 50, 65 and 80 dB SPL, Unaided Versus OSIA System at 4 Weeks, 3, 6 and 12 Months The change of hearing performance from the unaided hearing situation before surgery to the aided hearing situation with the OSIA System at 4 weeks, 3, 6 and 12 months, measured as free-field hearing test Speech in quiet at 50, 65 and 80 dB SPL [% correctly perceived words at 50, 65 and 80 dB SPL] is presented. The change in percent points is presented. A positive value indicates an improved ability to perceive words in quiet at the specified decibel (dB) level a negative value represent an impairment. Baseline before surgery, 4 weeks, 3, 6 and 12 months after surgery.
Secondary Adaptive Speech Recognition in Noise, Unaided Versus OSIA System at 4 Weeks, 6 and 12 Months The change of hearing performance from the unaided hearing situation before surgery to the aided hearing situation with the OSIA System at 3 months measured as free field hearing test Adaptive speech recognition in noise, is presented. Adaptive speech recognition in noise was measured as Signal to Noise Ratio (SNR). The noise was kept constant at 65 dB SPL and the speech was adapted in dB steps to establish the Speech-to-Noise Ratio (SNR) providing a 50% level of understanding. A ratio of 0 reflects the ability to correctly hear sentences at 65 dB, in the presence of 65 dB background noise. A negative SNR-value reflects the ability to correctly hear sentences below 65 dB, for example if 50% of the speech is received correctly at 55 dB the SNR value is -10. A positive SNR-value (Speech to Noise Ratio) reflects the ability to correctly hear sentences presented above 65 dB. A lower or more negative score is more desirable and reflects a better hearing in a noisy environment. Baseline before surgery, 4 weeks, 6 and 12 months after surgery
Secondary Abbreviated Profile of Hearing Aid Benefit (APHAB) at 3 and 12 Months The change of Ease of communication, Reverberation, Background noise, Aversiveness and a Global score from the unaided hearing situation before surgery to the aided hearing situation with the OSIA System at 3 and 12 months is presented. All subscales range from 0-100%, total score is the average of all subscales 0-100%, where 0% indicates no problem and 100% indicates always problem. The difference between the unaided and the aided situation is presented. In an ultimate case the unaided value could be 100 and the aided 0, the result is then 100. A positive value indicates an improvement, a negative value an impairment. Baseline before surgery, 3 and 12 months after surgery
Secondary Health Utility Index (HUI) at 3 and 12 Months The change of health status and health related quality of life from the unaided hearing situation before surgery to the aided hearing situation with the OSIA System at 3 and 12 months using the generic quality of life scale Health Utilities Index (HUI3) is presented. All subscales (comprehensive health state, vision, hearing, speech, ambulation, dexterity, emotion, pain, cognition) range from 0-1. A health utility value of 1.00 indicates perfect health while a score of 0.00 indicates death. The difference between the unaided and the aided situation is presented. In an ultimate case the unaided value could be 0 and the aided 1, the result is then 1.0. A positive value indicates an improved quality of life, a negative value indicates impaired quality of life. Baseline before surgery and 3 and 12 months after surgery
Secondary Speech, Spatial and Qualities of Hearing Scale (SSQ) at 3 and 12 Months The change of speech, spatial and hearing experiences from the unaided hearing situation before surgery to the aided hearing situation with the OSIA System at 3 and 12 months using the SSQ scale is presented. All subscales (speech, spatial, quality) range from 0 to 10, where 0 represents "can not hear at all", and 10 "hear perfectly". Total score is a average of the subscales. A positive value indicates improved hearing, a negative value indicates impaired hearing. Baseline before surgery and 3 and 12 months after surgery
Secondary Hearing Performance: Threshold Audiometry PTA4, With Reference Device BP110 The change of hearing performance with the OSIA System at 4 weeks, 3, 6 and 12 months compared to the pre-operative aided situation with BP110 on softband, measured as free-field hearing test; Threshold audiometry PTA4 (mean of 500, 1000, 2000 and 4000 Hz) is presented. The units reported for PTA4 are decibels (dB). A lower or more negative score is more desirable and reflects a better ability to hear softer sounds. Baseline before surgery, 4 weeks, 3, 6 and 12 months.
Secondary Hearing Performance: Threshold Audiometry Individual Frequences With Reference Device BP110 The change of hearing performance with the OSIA System at 4 weeks, 3, 6 and 12 months compared to the pre-operative aided situation with BP110 on softband, measured as free-field hearing test; Threshold audiometry individual frequencies (0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 kHz) is presented. The units reported are decibels (dB). A lower or more negative score is more desirable and reflects a better ability to hear softer sounds. Baseline before surgery, 4 weeks, 3, 6 and 12 months after surgery.
Secondary Speech in Quiet at 50, 65 and 80 dB SPL, With Reference Device BP110 The change of hearing performance with the OSIA System at 4 weeks, 3, 6 and 12 months compared to the pre-operative aided situation with BP110 on softband measured as free-field hearing test; Speech in quiet [% correctly perceived words at 50, 65 and 80 dB SPL]. The change in percent points is presented. A positive value indicates an improved ability to perceive words in quiet at the specified decibel (dB) level a negative value represent an impairment. Baseline before surgery, 4 weeks, 3, 6 and 12 months after surgery.
Secondary Adaptive Speech Recognition in Noise, With Reference Device BP110 The change of hearing performance with the OSIA System at 4 weeks, 3, 6 and 12 months compared to the pre-operative aided situation with BP110 on softband;measured with free field hearing test Adaptive speech recognition in noise which was measured as signal to noise ratio (SNR). The noise was kept constant at 65 dB SPL and the speech was adapted in dB steps to establish the speech-to-noise ratio (SNR) providing a 50% level of understanding. A ratio of 0 reflects the ability to correctly hear sentences at 65 dB, in the presence of 65 dB background noise. A negative SNR-value reflects the ability to correctly hear sentences below 65 dB. A positive SNR-value reflects the ability to correctly hear sentences presented above 65 dB. A lower or more negative score is more desirable and represent a better hearing in a noisy environment. Baseline before surgery, 4 weeks, 3, 6 and 12 months after surgery.
Secondary Surgical Information: Time of Surgery Surgery time in minutes between first incision and last suture Visit 2, surgery
Secondary Soft Tissue Thickness Surgical information: Soft tissue thickness was measured in mm Visit 2, surgery
Secondary Soft Tissue Reduction Surgical information: a question was asked if soft tissue reduction had been performed. Could be answered by ticking a box for "Yes" or "No". Visit 2, surgery
Secondary Bone Polishing/Removal at Implant Site Surgical information: a question is asked if bone polishing/removal at Implant site has been performed. Yes or No can be ticked. Visit 2, surgery
Secondary Type of Anaesthesia Surgical information: a question is asked which type of anaesthesia has been used: local or general can be ticked. Visit 2, surgery
Secondary Location of BI300 Implant Surgical information: where is the location of the BI300 implant, measured in two different ways:
Alternative 1 used for the first 6 subjects: Location from the ear channel in mm.
Alternative 2 used for the rest of the population 45 subjects, after an amendment: measured in mm horizontally and vertically from ear channel. and the distance in mm between the receiver and the coil.
Value 9.64 mm vertically from ear channel is correct.
Visit 2, surgery
Secondary Incision Type Surgical information: a question was asked regarding what type of incision had been used; C-shaped flap, posterior based flap or other could be ticked. Visit 2, surgery
Secondary Daily Usage Time of Sound Processor Sound processor usage time measured as hours per day. 6 weeks, 3, 6 and 12 months
Secondary Comfort Comfort of sound processor measured with a visual analogue scale where 0% is defined as no comfort at all and 100% as most comfortable imaginable, i.e. minimum 0, maximum 100. 6 weeks, 3, 6 and 12 months
Secondary Magnet Choice Available magnet strengths: 1/2, 1, 2, 3, 4, 5 or 6, where 1/2 is the weakest and 6 the strongest. 4, 6 weeks, 3, 6 and 12 months
Secondary Softpad Use A question was asked if the subjects used softpads; yes or no could be ticked. 6 weeks, 3, 6 and 12 months
See also
  Status Clinical Trial Phase
Completed NCT03723161 - Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
Completed NCT04320407 - Osia CPT Code Study N/A
Active, not recruiting NCT01445977 - SoundBite Hearing System Long Term Multi Site Patient Use Study N/A
Completed NCT02304692 - Clinical Survey of Different Abutment Topologies N/A
Recruiting NCT00393159 - The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children Phase 4
Recruiting NCT06164184 - Interest of the Cone Beam Scanner of Temporal Bones in the Analysis of Conductive Hearing Loss
Not yet recruiting NCT01967498 - Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study N/A
Active, not recruiting NCT05628285 - Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear N/A
Completed NCT03374787 - Evaluation of Sound Processor for a Transcutaneous System N/A
Completed NCT02092610 - Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System N/A
Completed NCT01671176 - Wide Diameter Bone Anchored Implant Study N/A
Recruiting NCT01807559 - SoundBite Hearing System 24 Month Multi Site Patient Use Study N/A
Withdrawn NCT01264510 - Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha) Phase 4
Recruiting NCT04803279 - Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Completed NCT03143257 - Ambispective Clinical Evaluation of Sophono™
Completed NCT02274129 - Clinical Survey of Oticon Medical Healing Cap N/A
Withdrawn NCT03541967 - Comparison of a New Bone Conduction Hearing System to a Osteo-integrated Bone Conduction Hearing Aid on a Softband N/A
Recruiting NCT03327194 - Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss N/A
Completed NCT05000931 - Osia 2 Pediatric Expansion Study N/A
Completed NCT03746548 - Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini N/A